<- Go Home
Magellan Health, Inc.
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; programs for the integrated management of specialty drugs that treat complex conditions; and eMbrace, a fully integrated and evidence-based solution that supports members total wellbeing. Furthermore, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was formerly known as Magellan Health Services Inc. and changed its name to Magellan Health, Inc. in June 2014. Magellan Health, Inc. was incorporated in 1969 and is based in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.
Market Cap
$2.5B
Volume
234.4K
Cash and Equivalents
$958.7M
EBITDA
$86.8M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$123.0M
Profit Margin
2.55%
52 Week High
$99.36
52 Week Low
$82.94
Dividend
N/A
Price / Book Value
1.29
Price / Earnings
-314.74
Price / Tangible Book Value
2.49
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$28.9M
Return on Equity
0.16%
Return on Assets
0.54
Cash and Short Term Investments
$1.0B
Debt
$562.6M
Equity
$2.0B
Revenue
$4.8B
Unlevered FCF
$705.6M
Sector
Health Care Providers and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium